Drug Profile
Research programme: nanoparticle drug therapeutics - Nevakar
Alternative Names: Nanoparticle drugs - Nevakar; Nanoparticles - Nevakar; NVK 017Latest Information Update: 28 Oct 2021
Price :
$50
*
At a glance
- Originator Nevakar
- Class Anti-infectives; Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer